Serum levels of the S100A8/S100A9 heterodimer (calprotectin) were recently shown to be elevated in severe COVID‐19, and we can confirm significant upregulation of the respective genes in patient‐derived macrophages well beyond viral clearance. This evidence concerns the gene S100A8 and COVID-19.